Editorial: the role of colonic inflammation in the progression of liver disease in primary sclerosing cholangitis—Authors’ reply and Letter: the effects of colectomy prior to the diagnosis of primary sclerosing cholangitis on prognosis may have been overestimated

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 441-442

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 753-762

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical profiles of patients with primary sclerosing cholangitis in the elderly

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 3, 2015-03 ,pp. : 230-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antitumor necrosis α treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 11, 2015-11 ,pp. : 1455-1456

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver transplantation and whipple surgery combined with chemoradiotherapy for treatment of hilar cholangiocarcinoma in patients with primary sclerosing cholangitis

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 5, 2015-05 ,pp. : 696-699

John Wiley & Sons Inc

Access to resources Recommend Favorite